Hsueh-Chou Lai Selected Research

Sorafenib (BAY 43-9006)

11/2023	Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion.
7/2021	On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma.
3/2020	Androgen Receptor Enhances the Efficacy of Sorafenib Against Hepatocellular Carcinoma Through Enriched EpCAM Stemness.
1/2020	Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
4/2016	Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hsueh-Chou Lai Research Topics

Disease

36	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2010
29	Chronic Hepatitis C 04/2024 - 05/2009
19	Fibrosis (Cirrhosis) 04/2024 - 06/2014
18	Infections 04/2024 - 09/2004
18	Chronic Hepatitis B 01/2023 - 12/2010
17	Neoplasms (Cancer) 04/2024 - 01/2008
8	Virus Diseases (Viral Diseases) 04/2023 - 03/2010
6	Hepatitis C 03/2024 - 01/2015
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 08/2012
6	Liver Diseases (Liver Disease) 10/2021 - 07/2012
5	Liver Neoplasms (Liver Cancer) 04/2024 - 12/2015
5	Diabetes Mellitus 04/2024 - 01/2015
4	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2010
4	Hepatitis B 01/2017 - 07/2012
3	Zika Virus Infection 12/2021 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 11/2019 - 01/2017
3	Medically Unexplained Symptoms 01/2019 - 01/2015
3	Disease Progression 01/2018 - 07/2016
3	Inflammation (Inflammations) 06/2017 - 02/2009
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2013
2	Hepatitis 04/2024 - 06/2014
2	Fatty Liver 01/2024 - 06/2014
2	Cholelithiasis 05/2021 - 03/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021 - 06/2013
2	Diarrhea 06/2019 - 03/2019
2	Gastroesophageal Reflux (GERD) 03/2019 - 01/2012
2	Cholecystitis 01/2019 - 06/2013
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 01/2016
2	Pancreatitis 01/2018 - 06/2015
2	Gallstones (Gallstone) 08/2016 - 06/2013
2	Pyogenic Liver Abscess 01/2015 - 04/2008
2	Hemorrhage 01/2008 - 09/2004
2	Peptic Ulcer (Peptic Ulcers) 03/2005 - 09/2004
2	Ulcer 03/2005 - 09/2004
1	Hyperbilirubinemia 04/2023
1	Obesity 01/2023
1	COVID-19 01/2023
1	Cachexia 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022

Drug/Important Bio-Agent (IBA)

29	Antiviral Agents (Antivirals)IBA 04/2024 - 05/2009
14	InterferonsIBA 01/2022 - 03/2010
11	entecavir FDA Link 01/2023 - 01/2017
10	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 05/2009
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2020 - 04/2010
6	Interferon-alpha (Interferon Alfa)IBA 02/2020 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2018
5	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 04/2016
5	AlbuminsIBA 01/2023 - 08/2016
5	Hepatitis B e AntigensIBA 05/2020 - 12/2010
5	Androgen Receptors (Androgen Receptor)IBA 03/2020 - 06/2014
5	Proton Pump InhibitorsIBA 03/2019 - 06/2013
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2012
4	BilirubinIBA 04/2023 - 07/2021
4	Fetal Proteins (Fetoprotein)IBA 01/2023 - 01/2017
3	CollagenIBA 01/2024 - 01/2015
3	Tenofovir (Viread)FDA Link 01/2023 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
3	velpatasvirIBA 01/2022 - 04/2021
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2017
3	SofosbuvirIBA 01/2022 - 04/2021
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2023
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 10/2022 - 04/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2009
2	EnzymesIBA 07/2018 - 01/2017
2	Eicosapentaenoic AcidIBA 06/2017 - 03/2010
2	Arachidonic Acid (Vitamin F)IBA 06/2017 - 03/2010
2	CytokinesIBA 06/2017 - 02/2009
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2017 - 03/2010
2	AndrogensIBA 01/2017 - 06/2014
2	Indicators and Reagents (Reagents)IBA 01/2014 - 08/2012
2	Capsules (Microcapsules)IBA 07/2009 - 01/2008
2	UreaseIBA 03/2005 - 09/2004
1	SirtuinsIBA 04/2024
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024
1	Lipoproteins (Lipoprotein)IBA 01/2024
1	oxidized low density lipoproteinIBA 01/2024
1	VLDL LipoproteinsIBA 01/2024
1	Hyaluronic Acid (Hyaluronan)IBA 01/2024
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 04/2023
1	pazopanib FDA Link 01/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022

Therapy/Procedure

51	Therapeutics 04/2024 - 03/2005
4	Cholecystectomy 05/2021 - 02/2007
2	Radiotherapy 04/2024 - 12/2016
2	Surgical Instruments (Clip) 01/2020 - 12/2016
2	Oral Administration 06/2019 - 03/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2019 - 12/2015
2	Peritoneal Dialysis 01/2018 - 02/2012
2	Liver Transplantation 07/2016 - 12/2008
1	Microspheres (Microsphere) 04/2024
1	Immunotherapy 01/2023
1	Hospice Care (Care, Bereavement) 10/2022